WAC 182-530-4150. Therapeutic interchange program (TIP)

This section contains the medicaid agency's rules for the endorsing practitioner therapeutic interchange program (TIP). TIP is established under RCW 69.41.190 and 70.14.050 . (1) TIP applies only to drugs: (a) Within therapeutic classes on the Washington preferred drug list (Washington PDL); (b) Included in a motion passed by the pharmacy and therapeutics (P&T) committee; and (c) Prescribed by an endorsing practitioner. (2) TIP does not apply to a drug when: (a) The P&T committee determines that TIP does not apply to the drug or its therapeutic class on the Washington PDL; (b) Prescribed by a nonendorsing practitioner; (c) The endorsing practitioner signs the prescription "dispense as written (DAW)"; or (d) Otherwise prohibited under RCW 69.41.190 . (3) The agency may impose nonendorsing status on an endorsing practitioner only under the circumstances outlined in RCW 69.41.190 . (4) Except as otherwise provided in subsection (5) of this section, the agency may restrict a client's first course of treatment within a therapeutic class, according to the provisions in RCW 69.41.190 . (5) In accordance with WAC 182-530-4125 (3) and 182-501-0165 , the agency will request and review the endorsing practitioner's medical justification for preferred and nonpreferred brand name drugs and nonpreferred generic drugs for the client's first course of treatment.